Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Rank in Stocks #13761
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Share Price
$0.85814713
Last synced: 2025-05-14
Market Cap
$463.40M
Change (1 day)
-2.52%
Change (1 year)
0.00%
Country
GB
Trade Alliance Pharma plc (APH)

Category

P/B ratio for Alliance Pharma plc (APH)
P/B ratio as of August 2026 TTM: 1.68
According to Alliance Pharma plc latest financial reports and stock price the company's current price-to-book ratio (TTM) is 1.68. At the end of 2023 the company had a P/B ratio of 1.00.
P/B ratio history for Alliance Pharma plc from 2001 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 1.68 41.52%
2024 1.19 18.59%
2023 1.00 1.02%
2022 0.99 -51.79%
2021 2.06 26.75%
2020 1.63 1.85%
2019 1.60 20.91%
2018 1.32 -15.88%
2017 1.57 26.57%
2016 1.24 71.87%
2015 0.72 -47.00%
2014 1.36 -17.92%
2013 1.66 3.07%
2012 1.61 -12.45%
2011 1.84 -5.33%
2010 1.94 -42.47%
2009 3.38 475.56%
2008 0.59 -61.39%
2007 1.52 -25.05%
2006 2.03 -32.52%
2005 3.00 -62.85%
2004 8.09 102.91%
2002 3.99 -84.24%
2001 25.28 0.00%
P/B ratio for similar companies or competitors